See more : Arena Minerals Inc. (AN.V) Income Statement Analysis – Financial Results
Complete financial analysis of Unichem Laboratories Limited (UNICHEMLAB.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Unichem Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Imagination Technologies (IGZ) Income Statement Analysis – Financial Results
- aap Implantate AG (AAQ1.DE) Income Statement Analysis – Financial Results
- Canon Inc. (7751.T) Income Statement Analysis – Financial Results
- Canara Bank (CANBK.NS) Income Statement Analysis – Financial Results
- João Fortes Engenharia S.A. (JFEN3.SA) Income Statement Analysis – Financial Results
Unichem Laboratories Limited (UNICHEMLAB.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.unichemlabs.com
About Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.57B | 13.43B | 12.48B | 11.90B | 11.56B | 11.23B | 7.78B | 15.20B | 13.35B | 12.02B | 11.33B | 10.81B | 8.75B | 8.24B | 7.47B | 7.35B | 6.71B | 6.28B | 5.47B |
| Cost of Revenue | 13.40B | 5.51B | 4.41B | 4.01B | 4.09B | 4.67B | 3.72B | 5.29B | 4.70B | 4.49B | 3.95B | 3.95B | 3.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.17B | 7.92B | 8.07B | 7.89B | 7.47B | 6.56B | 4.07B | 9.91B | 8.65B | 7.53B | 7.38B | 6.86B | 5.19B | 8.24B | 7.47B | 7.35B | 6.71B | 6.28B | 5.47B |
| Gross Profit Ratio | 19.15% | 58.98% | 64.70% | 66.27% | 64.60% | 58.38% | 52.24% | 65.20% | 64.81% | 62.62% | 65.16% | 63.46% | 59.30% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 1.05B | 263.94M | 337.56M | 439.02M | 1.56B | 1.16B | 849.69M | 616.94M | 438.68M | 464.21M | 521.51M | 364.93M | 392.74M | 383.51M | 291.18M | 272.13M | 321.50M | 0.00 | 0.00 |
| General & Administrative | 432.93M | 333.22M | 324.77M | 364.23M | 493.35M | 341.09M | 236.42M | 304.98M | 295.78M | 2.26B | 209.01M | 941.00K | 979.07M | 6.36B | 5.47B | 5.66B | 5.53B | 5.35B | 4.59B |
| Selling & Marketing | 1.78B | 1.30B | 1.21B | 1.23B | 2.23B | 1.97B | 1.12B | 2.12B | 1.68B | 748.39M | 1.34B | 1.36B | 1.16B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.21B | 1.63B | 1.53B | 1.59B | 2.72B | 2.31B | 1.35B | 2.43B | 1.98B | 3.00B | 4.38B | 4.02B | 2.14B | 6.36B | 5.47B | 5.66B | 5.53B | 5.35B | 4.59B |
| Other Expenses | 0.00 | 385.15M | 5.15M | 50.64M | 7.22M | 26.16M | 15.85M | 70.43M | 62.99M | 68.55M | 72.37M | 53.73M | 74.36M | 223.56M | 165.76M | 129.37M | -53.47M | -12.56M | 133.87M |
| Operating Expenses | 6.73B | 9.81B | 8.18B | 7.81B | 8.78B | 7.92B | 5.89B | 8.57B | 7.37B | 6.93B | 6.06B | 5.42B | 4.31B | 6.96B | 5.93B | 6.06B | 5.96B | 5.39B | 4.67B |
| Cost & Expenses | 16.57B | 15.32B | 12.59B | 11.83B | 12.87B | 12.59B | 9.60B | 13.85B | 12.06B | 11.42B | 10.01B | 9.37B | 7.88B | 6.96B | 5.93B | 6.06B | 5.96B | 5.39B | 4.67B |
| Interest Income | 6.73M | 5.16M | 64.78M | 229.40M | 386.92M | 449.79M | 135.23M | 25.14M | 51.28M | 93.50M | 57.29M | 4.03M | 16.11M | 14.58M | 13.42M | 6.58M | 7.61M | 12.64M | 21.91M |
| Interest Expense | 226.61M | 173.13M | 50.21M | 44.68M | 71.21M | 70.40M | 77.96M | 31.36M | 27.27M | 29.58M | 31.90M | 32.90M | 40.78M | 23.92M | 23.83M | 25.55M | 21.95M | 24.87M | 38.24M |
| Depreciation & Amortization | 1.13B | 1.13B | 911.66M | 843.56M | 816.69M | 673.67M | 505.08M | 435.16M | 390.01M | 412.72M | 457.16M | 383.40M | 304.35M | 292.18M | 232.14M | 224.13M | 181.42M | 139.98M | 126.50M |
| EBITDA | 742.36M | -466.67M | 1.18B | 1.41B | 404.94M | 149.19M | -710.16M | -358.90M | 1.64B | 1.01B | 1.78B | 1.82B | 1.24B | 1.58B | 1.77B | 1.52B | 930.56M | 1.03B | 926.99M |
| EBITDA Ratio | 4.48% | -2.77% | 9.82% | 10.86% | 1.31% | 0.19% | -10.69% | 12.41% | 13.71% | 10.03% | 13.96% | 16.83% | 14.68% | 19.05% | 23.75% | 20.63% | 13.86% | 16.45% | 16.94% |
| Operating Income | 5.07M | -1.51B | -111.35M | 72.76M | -1.31B | -1.36B | -1.82B | 1.34B | 1.28B | 600.72M | 1.32B | 1.44B | 879.11M | 1.28B | 1.54B | 1.29B | 749.14M | 893.13M | 800.49M |
| Operating Income Ratio | 0.03% | -11.21% | -0.89% | 0.61% | -11.29% | -12.13% | -23.42% | 8.84% | 9.60% | 5.00% | 11.65% | 13.29% | 10.04% | 15.50% | 20.64% | 17.58% | 11.16% | 14.22% | 14.63% |
| Total Other Income/Expenses | -621.73M | -34.87M | -3.20B | 715.31M | 828.08M | 762.57M | 484.09M | -2.17B | 96.05M | 173.41M | 390.68M | 24.87M | 61.18M | -9.35M | -10.42M | -18.97M | -67.81M | -24.79M | 117.54M |
| Income Before Tax | -616.66M | -1.76B | 219.69M | 514.79M | -482.10M | -599.05M | -1.30B | 1.41B | 1.38B | 774.13M | 1.71B | 1.46B | 940.30M | 1.27B | 1.53B | 1.27B | 681.33M | 868.34M | 918.03M |
| Income Before Tax Ratio | -3.72% | -13.13% | 1.76% | 4.33% | -4.17% | -5.34% | -16.68% | 9.30% | 10.32% | 6.44% | 15.10% | 13.52% | 10.74% | 15.39% | 20.50% | 17.32% | 10.15% | 13.83% | 16.77% |
| Income Tax Expense | 88.08M | 258.65M | -110.93M | 171.55M | 119.72M | -343.48M | 33.42M | 325.80M | 292.74M | 21.32M | 430.04M | 328.47M | -227.72M | 315.90M | 304.30M | 192.00M | 172.50M | 165.85M | 115.00M |
| Net Income | -704.74M | -2.02B | 330.62M | 343.25M | -601.83M | -238.00M | 25.45B | 1.09B | 1.08B | 753.90M | 1.69B | 1.13B | 712.58M | 951.96M | 1.23B | 1.08B | 508.83M | 702.49M | 803.03M |
| Net Income Ratio | -4.25% | -15.06% | 2.65% | 2.88% | -5.20% | -2.12% | 327.05% | 7.15% | 8.10% | 6.27% | 14.94% | 10.48% | 8.14% | 11.55% | 16.43% | 14.71% | 7.58% | 11.19% | 14.67% |
| EPS | -10.01 | -28.73 | 4.70 | 4.88 | -8.55 | -3.38 | 280.59 | 11.96 | 11.90 | 8.31 | 18.69 | 12.52 | 7.89 | 10.53 | 13.66 | 11.99 | 5.70 | 7.79 | 9.04 |
| EPS Diluted | -10.01 | -28.73 | 4.68 | 4.88 | -8.55 | -3.38 | 280.41 | 11.96 | 11.88 | 8.29 | 18.63 | 12.48 | 7.86 | 10.47 | 13.58 | 11.98 | 5.70 | 7.79 | 9.02 |
| Weighted Avg Shares Out | 70.40M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M |
| Weighted Avg Shares Out (Dil) | 70.40M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M | 70.39M |
Source: https://incomestatements.info
Category: Stock Reports